8x8 Inc vs Elanco Animal Health Incorporated Common Stock — how do they compare? 8x8 Inc trades at $2.15 (market cap $311.98M), while Elanco Animal Health Incorporated Common Stock trades at $22.87 (market cap $11.26B). The key difference: Elanco Animal Health Incorporated Common Stock is far larger — about 36.1× 8x8 Inc's market cap, and Elanco Animal Health Incorporated Common Stock is more actively traded (4,570,386 versus 1,639,086). Which is the better fit depends on your goals — on Pluang, investors hold 8x8 Inc for 16 Days and Elanco Animal Health Incorporated Common Stock for 0 Days on average.
| EGHT | ELAN | |
|---|---|---|
Market Cap | $311.98M | $11.26B |
Volume | 1,639,086 | 4,570,386 |
Sector | Technology | Health |
52-Week High | $2.76 | $26.84 |
52-Week Low | $1.59 | $19.76 |
Typical Hold Time | 16 Days | 0 Days |
Enterprise Value | $578.90M | $14.65B |
Signals from Pluang's Aura AI — not financial advice
EGHT trades at $2.15, up 0.47% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $27.21M in 2025 but shows improving trends with revenue growth to $745M and a projected net profit of $5M in 2026. Recent news highlights cost-saving client wins and AI product growth, while analyst consensus is a Buy with a $19.77 price target, suggesting significant upside potential from current levels.
The outlook is cautiously optimistic, with earnings beats and projected profitability offering opportunity, but high debt and thin margins pose risks. Investor sentiment is mixed amid valuation concerns, yet institutional interest and strategic partnerships support a positive long-term view if execution improves.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →